Patent: 5,102,796
✉ Email this page to a colleague
Summary for Patent: 5,102,796
Title: | Plant structural gene expression |
Abstract: | The invention provides genetically modified plant cells having a plant structural gene introduced and expressed therein under the control of a T-DNA promoter. In particular, the invention provides genetically modified plant cells having the phaseolin gene introduced and expressed therein under the control of a T-DNA promoter. Also provided are novel strains of bacteria containing and replicating T-DNA which has been modified to contain an inserted plant structural gene under the control of a T-DNA promoter. Further, the invention provides plasmids having the ability to replicate in E. coli and comprising T-DNA which has been modified to contain an inserted plant structural gene under the control of a T-DNA promoter. |
Inventor(s): | Hall; Timothy C. (College Station, TX), Kemp; John D. (Las Cruces, NM), Slightom; Jerry L. (Kalamazoo, IL), Sutton; Dennis W. (Las Cruces, NM) |
Assignee: | Lubrizol Genetics, Inc. (Wickliffe, OH) |
Application Number: | 07/144,775 |
Patent Claims: | see list of patent claims |
Details for Patent 5,102,796
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2009-04-07 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2009-04-07 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2009-04-07 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |